Lycia Therapeutics Statistics
NASDAQ: LYCAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
33.07+1.30 (+4.09%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Lycia Therapeutics by the numbers
Lycia Therapeutics has a market capitalization of $1.72 billion based on 52.09M shares outstanding. With trailing EPS of $-1.04, Lycia Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.0% above its 50-day average and 12.0% above its 200-day average.
Average daily trading volume is 432.72K shares, or about $14.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LYCA valuation vs. peer median
| Metric | LYCA | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.72B | $1.64B | +5% |
| Avg. volume | 432.72K | 1.79M | -76% |
Peer median across 8 companies: MAZE, REPL, COAG, BCRX, VIR, RXRX, ALVO, WWB.
Valuation
- Market cap
- $1.72B
- EPS (TTM)
- $-1.04
- Shares outstanding
- 52.09M
Price and trading
- Previous close
- 31.77
- Open
- 31.86
- Day range
- 31.01 – 34.59
- 52-week range
- 22.19 – 36.49
- Beta
- —
- Volume
- 422.14K
- Average volume
- 432.72K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 1.72B
- Forward Pe
- -26.25
- Eps
- -1.04
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 36.49
- Week52 Low
- 22.19
- Avg Volume
- 432.72K
- Shares Outstanding
- 52.09M
- Ma50
- 29.52
- Ma200
- 29.52
- Pct From52w High
- -9.37%
- Pct From52w Low
- 49.03%